Search publications

Publications

  • Siddi S, Bailon R, Giné I, Matcham F, Lamers F, Kontaxis S, Laporta E, Garcia E, Lombardini F, Annas P, Hotopf M, Penninx BWJH, Ivan A, White KM, Difrancesco S, Locatelli P, Aguiló J, Peñarrubia-María MT, Narayan VA, Folarin A, Leightley D, Cummins N, Vairavan S, Ranjan Y, Rintala A, de Girolamo G, Simblett SK, Wykes T, Myin-Germeys I, Dobson R and Haro JM.

    The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severity

    PSYCHOLOGICAL MEDICINE . 53(8): 3249-3260.

    [doi:10.1017/S0033291723001034]

  • Serra C, Vila R, del Cacho N, Butjosa A, Manuel Abella Villena, Colomer A, Cunill R, Tena MC, Véliz DI, Bustos-Cardona T, Dolz M, Profep Group and Usall J.

    Association of perceived social support with sociodemographic, clinical, and psychosocial variables in patients with first-episode psychosis.

    JOURNAL OF PSYCHIATRIC RESEARCH . 162: 30-36. Number of citations: 1

    [doi:10.1016/j.jpsychires.2023.04.008]

  • Parody-Rua E, Bustamante A, Montaner J, Rubio-Valera M, Serrano D, Pérez-Sánchez S, Sanchez A, Guevara-Cuellar C and Serrano-Blanco A.

    Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.

    EUROPEAN JOURNAL OF HEALTH ECONOMICS . 24(4): 621-632.

    [doi:10.1007/s10198-022-01495-1]

  • Novais T, Fortini C, Dima AL, Schott AM, Viprey M and Schneider MP.

    Se former à l’entretien motivationnel pour mieux soutenir l’adhésion thérapeutique des patients

    Revue Medicale Suisse . 19(823): 777-781.

    [doi:10.53738/REVMED.2023.19.823.777]

  • Sanabria JP, Doval E, Bernadàs A, Angarita-Osorio N, Colomer A, Evans-Lacko S, Thornicroft G, Luciano JV and Rubio-Valera M.

    Over 40 years (1981-2023) assessing stigma with the Community Attitudes to Mental Illness (CAMI) scale: a systematic review of its psychometric properties

    Systematic Reviews . 12(1): 66-66.

    [doi:10.1186/s13643-023-02230-4]

  • Lavalle R, Condominas E, Haro JM, Giné I, Bailon R, Laporta E, Garcia E, Kontaxis S, Alacid GR, Lombardini F, Preti A, Peñarrubia-María MT, Coromina M, Arranz B, Vilella E, Rubio E, Radar-Mdd Spain, Matcham F, Lamers F, Hotopf M, Penninx BWJH, Annas P, Narayan V, Simblett SK, Siddi S and The Radar-Cns Consortium.

    The Impact of COVID-19 Lockdown on Adults with Major Depressive Disorder from Catalonia: A Decentralized Longitudinal Study.

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 20(6): .

    [doi:10.3390/ijerph20065161]

  • Kardas, P, Agh, T, Dima AL, Goetzinger, C, Potocnjak, I, Wettermark, B and van Boven, JFM.

    Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?

    Pharmaceutics . 15(3): . Number of citations: 3

    [doi:10.3390/pharmaceutics15030933]

  • Cuñat O, Del Hoyo-Buxo B, Vila R, Serra C, Butjosa A, del Cacho N, Colomer A, Dolz M, Cuevas-Esteban J, Iglesias M, Usall J and Profep Group.

    Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)

    Asian Journal of Psychiatry . 81: 103448-103448. Number of citations: 1

    [doi:10.1016/j.ajp.2023.103448]

  • Bhattacharya D, Brown TJ, Clark AB, Dima AL, Easthall C, Taylor N and Li Z.

    Validation of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) ; a Behavioural Science-Underpinned Tool for Identifying Non-Adherence and Diagnosing an Individual's Barriers to Adherence

    PATIENT PREFERENCE AND ADHERENCE . 17: 2991-3000.

    [doi:10.2147/PPA.S427207]

  • Viprey M, Mougeot F, Dima AL, Haesebaert J, Occelli P, Durieu I, Rouzé H, Reynaud Q and Touzet S.

    A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit

    PATIENT PREFERENCE AND ADHERENCE . 17: 995-1004.

    [doi:10.2147/PPA.S389792]